KMB
Kimberly Clark Corp Materials Converted Paper & Paperboard Prods (No Contaners/Boxes) S&P 500Russell 3000
$107.94Close
$35.8BMarket cap
$90.70 – $114.3652-week range
Nov 5, 2026Next report · before the open
Highlights
Cautions
- Trend not confirmed 6 of 8 conditions · under 30% off the low, RS under 70
- Distribution down-day volume 1.7× up-day volume over 50 sessions
- Earnings shrinking EPS −32% year on year
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
6%
1wk
down 2.0%
price change
1mo
up 10.8%
price change
12-month return
down 6%
market up 11% ·
its own down 14%
F-score
6 / 9
Mixed
Altman Z
3.45
Low risk
P/E
17.7×
price / earnings
PEG
—
P/E / EPS growth
P/B
23.9×
price / book
Earnings yield
up 5.6%
EBIT / enterprise value
Cheaper than
47%
of the market · around average
Revenue growth
down 2%
year on year
EPS growth
down 32%
latest quarter · -50 pts
Sales growth
up 1%
latest quarter · -2 pts
ROE
up 173%
return on equity
Free cash margin
up 10%
$1.6B FCF
D/E
4.58
long-term debt / equity
Net debt / EBITDA
2.0×
Interest cover
9.2×EBIT / interest
Piotroski tests
- profitability slipped from last year
- short-term liquidity weakened
- gross margin narrowed
- profitable on its assets
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- no new shares issued
- assets working harder
Repair signals
- Long-term debt down 7% ($7.4B → $6.9B)
Trade setup
ATR%
2.4%
$2.60 a day · 2×ATR $102.73
RS
53 / 99
vs the universe
Trend
6 / 8
under 30% off the low, RS under 70
Relative volume
2.2×
vs 50-day average
Up/down volume
0.59
50 sessions
Implied move
4.2%
by Nov 6, 2026 · report Nov 5, 2026
Trend template · 6 of 8
- At least 30% above the 52-week low: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Gross margin narrowing Gross margin fell from 37.4% to 36.0%. The company is keeping less of each dollar of sales than it did a year ago.
- Revenue shrinking Revenue fell 2.1% over the year, from $16.8B to $16.4B.
Last reported
Oct 15, 2026
Results reaction
Oct 15, 2026+7% vs market2 sessions after results
Options
$732,26029.6% IV · activity
Financials
- Gross 36%
- Net 12%
- Free cash 10%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $19.1B | $19.4B | $17.0B | $17.1B | $16.8B | $16.4B |
| Gross margin | 36% | 31% | 33% | 37% | 37% | 36% |
| Operating income | $3.2B | $2.6B | $2.3B | $1.9B | $2.7B | $2.4B |
| Net income | $2.4B | $1.8B | $1.9B | $1.8B | $2.5B | $2.0B |
| Net margin | 12% | 9% | 11% | 10% | 15% | 12% |
| Earnings per share | $6.87 | $5.35 | $5.72 | $5.21 | $7.55 | $6.07 |
| Free cash flow | $2.5B | $1.7B | $1.9B | $2.8B | $2.5B | $1.6B |
| Free cash margin | 13% | 9% | 11% | 16% | 15% | 10% |
| Cash | $303.0M | $270.0M | $427.0M | $1.1B | $1.0B | $688.0M |
| Long-term debt | $8.1B | $8.5B | $8.0B | $7.9B | $7.4B | $6.9B |
| Shareholders' equity | $626.0M | $514.0M | $547.0M | $915.0M | $840.0M | $1.5B |
| Shares outstanding | 338.70m | 336.80m | 337.50m | 337m | 331.80m | 331.90m |
Next report
Nov 5, 2026 · before the open
Expected move The move, either way, the option market prices in through the next scheduled report: the at-the-money straddle for the first expiry that contains it, over the price. It includes the days around the report, so it slightly overstates the report alone. Methodology
±4.2%
$104 – $113 by Nov 6, 2026
Usual move The median, over the company's last four reports, of how far the stock moved either way from the close before the filing to the close of the session after it. Methodology
±3.3%
last 4: +6.2% · +4.5% · -2.2% · -1.6%
Expected against usual The move the options price through this report over the move the last four reports delivered. Above 1 the event is priced bigger than the company's own record; below 1, smaller. A price, not a forecast: it says what protection through the report costs, not which way the stock will go. Methodology
Bigger than usual
1.3× the usual move
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $101 – $116 ±6.7% by Nov 27, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- About the same 29.6% priced · 30.3% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- Choppier
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs less
Positioning
- Premium traded
- $732,260 calls $528,084 · puts $204,175 · latest session
- 0.39× +0.29 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +1.28k · puts -2.37k past week
For options traders: ATM IV 29.6% (+1.6% 1w) · 1m ÷ 3m IV 1.15 · 25Δ skew 0.5 pts · Net GEX $11.1M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 4, 2026 | Quarterly ↗ | Jun 30, 2026 | 35d |
| Apr 28, 2026 | Quarterly ↗ | Mar 31, 2026 | 28d |
| Feb 12, 2026 | Annual ↗ | Dec 31, 2025 | 43d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Aug 1, 2025 | Quarterly ↗ | Jun 30, 2025 | 32d |
| Apr 22, 2025 | Quarterly ↗ | Mar 31, 2025 | 22d |
| Feb 13, 2025 | Annual ↗ | Dec 31, 2024 | 44d |
| Oct 22, 2024 | Quarterly ↗ | Sep 30, 2024 | 22d |
| Jul 23, 2024 | Quarterly ↗ | Jun 30, 2024 | 23d |
| Apr 23, 2024 | Quarterly ↗ | Mar 31, 2024 | 23d |
| Feb 8, 2024 | Annual ↗ | Dec 31, 2023 | 39d |
| Oct 24, 2023 | Quarterly ↗ | Sep 30, 2023 | 24d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Material agreement · New obligation · Other events ↗ |
| Oct 28, 2026 | Other events ↗ |
| Oct 20, 2026 | Other events ↗ |
| Oct 15, 2026 | Results · Regulation FD ↗ |
| Oct 13, 2026 | Other events ↗ |
| Oct 1, 2026 | Director or officer change ↗ |
| Sep 28, 2026 | Other events ↗ |
| Aug 4, 2026 | Results ↗ |
| May 14, 2026 | Shareholder vote ↗ |
| May 5, 2026 | Director or officer change ↗ |
| Apr 28, 2026 | Results ↗ |
| Jan 29, 2026 | Shareholder vote · Regulation FD ↗ |